Health
Merck drug extends survival in endometrial cancer trial, wins U.S. priority review
TL;DR
- The drug delivers a cancer-killing payload to cells that carry a protein common in endometrial tumours
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Oct 27, 2026 · Updated 10/28/2026, 6:44:43 PM · Reported with: The Hindu Health
Sources (1)
NRI Bytes writes its own articles from the reporting below.
The Hindu Health — Merck drug extends survival in endometrial cancer trial, wins U.S. priority reviewUp next · Health
Lift Falls in Nalasopara Building, Eight Injured
Read next →
